Correlation Between Pharvaris and NervGen Pharma

Can any of the company-specific risk be diversified away by investing in both Pharvaris and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharvaris BV and NervGen Pharma Corp, you can compare the effects of market volatilities on Pharvaris and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and NervGen Pharma.

Diversification Opportunities for Pharvaris and NervGen Pharma

0.68

Correlation Coefficient

Pharvaris  NervGen Pharma

Poor diversification

The 3 months correlation between Pharvaris and NervGen is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Pharvaris i.e., Pharvaris and NervGen Pharma go up and down completely randomly.

Pair Corralation between Pharvaris and NervGen Pharma

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the NervGen Pharma. In addition to that, Pharvaris is 1.54 times more volatile than NervGen Pharma Corp. It trades about -0.09 of its total potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.13 per unit of volatility. If you would invest  216.00  in NervGen Pharma Corp on December 30, 2024 and sell it today you would lose (32.00) from holding NervGen Pharma Corp or give up 14.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharvaris BV  vs.  NervGen Pharma Corp

Pharvaris BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

NervGen Pharma Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Pharvaris and NervGen Pharma

The main advantage of trading using opposite Pharvaris and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.

The idea behind Pharvaris BV and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.